Biostem Technologies Stock Market Value
| BSEM Stock | USD 14.44 0.98 6.36% |
| Symbol | Biostem |
Biostem Technologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biostem Technologies' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biostem Technologies.
| 10/23/2024 |
| 12/22/2024 |
If you would invest 0.00 in Biostem Technologies on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Biostem Technologies or generate 0.0% return on investment in Biostem Technologies over 60 days. Biostem Technologies is related to or competes with Genfit, HCW Biologics, Protara Therapeutics, Genelux Common, Dyadic International, Cingulate, and Monopar Therapeutics. BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutica... More
Biostem Technologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biostem Technologies' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biostem Technologies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.45 | |||
| Information Ratio | 0.1083 | |||
| Maximum Drawdown | 43.73 | |||
| Value At Risk | (6.97) | |||
| Potential Upside | 12.51 |
Biostem Technologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biostem Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biostem Technologies' standard deviation. In reality, there are many statistical measures that can use Biostem Technologies historical prices to predict the future Biostem Technologies' volatility.| Risk Adjusted Performance | 0.0982 | |||
| Jensen Alpha | 0.8259 | |||
| Total Risk Alpha | 0.6075 | |||
| Sortino Ratio | 0.106 | |||
| Treynor Ratio | (1.25) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biostem Technologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biostem Technologies Backtested Returns
Biostem Technologies appears to be slightly risky, given 3 months investment horizon. Biostem Technologies secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12% return per unit of risk over the last 3 months. By analyzing Biostem Technologies' technical indicators, you can evaluate if the expected return of 0.85% is justified by implied risk. Please makes use of Biostem Technologies' Mean Deviation of 5.19, risk adjusted performance of 0.0982, and Downside Deviation of 7.45 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Biostem Technologies holds a performance score of 9. The firm shows a Beta (market volatility) of -0.65, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Biostem Technologies are expected to decrease at a much lower rate. During the bear market, Biostem Technologies is likely to outperform the market. Please check Biostem Technologies' sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether Biostem Technologies' price patterns will revert.
Auto-correlation | 0.47 |
Average predictability
Biostem Technologies has average predictability. Overlapping area represents the amount of predictability between Biostem Technologies time series from 23rd of October 2024 to 22nd of November 2024 and 22nd of November 2024 to 22nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biostem Technologies price movement. The serial correlation of 0.47 indicates that about 47.0% of current Biostem Technologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.47 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 2.16 |
Biostem Technologies lagged returns against current returns
Autocorrelation, which is Biostem Technologies otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biostem Technologies' otc stock expected returns. We can calculate the autocorrelation of Biostem Technologies returns to help us make a trade decision. For example, suppose you find that Biostem Technologies has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biostem Technologies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biostem Technologies otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biostem Technologies otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biostem Technologies otc stock over time.
Current vs Lagged Prices |
| Timeline |
Biostem Technologies Lagged Returns
When evaluating Biostem Technologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biostem Technologies otc stock have on its future price. Biostem Technologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biostem Technologies autocorrelation shows the relationship between Biostem Technologies otc stock current value and its past values and can show if there is a momentum factor associated with investing in Biostem Technologies.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Biostem OTC Stock
Biostem Technologies financial ratios help investors to determine whether Biostem OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biostem with respect to the benefits of owning Biostem Technologies security.